LINCS: L-NAME (a NO synthase inhibitor) in the treatment of refractory cardiogenic shock: a prospective randomized study.
LINCS: L-NAME (a NO synthase inhibitor) in the treatment of refractory cardiogenic shock: a prospective randomized study.
G. Cotter,E. Kaluski,6 Authors,Z. Vered
2003 · DOI: 10.1016/S0195-668X(03)00193-3
European Heart Journal · 159 Citations
TLDR
The results of the present study further support the previous observation that NO synthase inhibitors are beneficial in the treatment of patients with refractory cardiogenic shock.